Evidence
Parasit Vectors. 2024 Jun 28;17(1):276. doi: 10.1186/s13071-024-06347-w.
ABSTRACT
BACKGROUND: Female Aedes aegypti mosquitoes can spread disease-causing pathogens when they bite humans to obtain blood nutrients required for egg production. Following a complete blood meal, host-seeking is suppressed until eggs are laid. Neuropeptide Y-like receptor 7 (NPYLR7) plays a role in endogenous host-seeking suppression and previous work identified small-molecule NPYLR7 agonists that inhibit host-seeking and blood-feeding when fed to mosquitoes at high micromolar doses.
METHODS: Using structure-activity relationship analysis and structure-guided design we synthesized 128 compounds with similarity to known NPYLR7 agonists.
RESULTS: Although in vitro potency (EC50) was not strictly predictive of in vivo effect, we identified three compounds that reduced blood-feeding from a live host when fed to mosquitoes at a dose of 1 μM-a 100-fold improvement over the original reference compound.
CONCLUSIONS: Exogenous activation of NPYLR7 represents an innovative vector control strategy to block mosquito biting behavior and prevent mosquito-human host interactions that lead to pathogen transmission.
PMID:38937807 | DOI:10.1186/s13071-024-06347-w
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- AI-driven convolutional neural networks for accurate identification of yellow fever vectors
- AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
- Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists
- IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders:An emerging pharmacotherapeutic target
- Postoperative use of sleep aids and delirium in older adults after major surgery: A retrospective cohort study
- The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review
- The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review
- Effects of Selective and Mixed-Action Kappa and Delta Opioid Receptor Agonists on Pain-Related Behavioral Depression in Mice
- Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening
- Underlying mechanisms for psychotropic effects of delta opioid receptor agonists
- A µ-opioid receptor modulator that works cooperatively with naloxone
- The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
- International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
- International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
- P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier
- Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
- Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
- Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
- Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans
- Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease
- Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837
- Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy
- Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity
- Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease
- Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease
- Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease
- GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review
- Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia
- Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release
- Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release
- The Alk receptor tyrosine kinase regulates Sparkly, a novel activity regulating neuropeptide precursor in the Drosophila central nervous system
- Ectonucleotidase Activity in Smooth Muscle Tissues of Rats with a Valproate Model of Autism
- Elafibranor PPARα/δ Dual Agonist Ameliorates Ovalbumin-Induced Allergic Asthma
- DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease
- Cerebellar damage with inflammation upregulates oxytocin receptor expression in Bergmann Glia
- Activation of Neuropeptide Y (NPY) receptors in the basolateral amygdala (BLA) inhibits projections to the bed nucleus of the stria terminalis (BNST) and buffers stress-induced decreases in social interaction in male rats
- The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling
- The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling
- Generative design of compounds with desired potency from target protein sequences using a multimodal biochemical language model
- Efficacy and tolerability of brexpiprazole - a new antipsychotic drug from the group of dopamine D2 receptor partial agonists
- Efficacy and tolerability of brexpiprazole - a new antipsychotic drug from the group of dopamine D2 receptor partial agonists
- Glucagon-like peptide receptor agonists and risk for depression
- Glucagon-like peptide receptor agonists and risk for depression
- Assessing suicide risk in chronic pain management: a narrative review across drug classes
- Mapping the molecular motions of 5-HT3 serotonin-gated channel by voltage-clamp fluorometry
- Neuropeptide Y receptor activation preserves inner retinal integrity through PI3K/Akt signaling in a glaucoma mouse model
- Neuropeptide Y receptor activation preserves inner retinal integrity through PI3K/Akt signaling in a glaucoma mouse model
- Summary for Patients: Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes
- Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor
- GLP-1 receptor agonists and weight loss in schizophrenia - past, present, and future
- Preclinical in vitro and in vivo results of the new silk vista flow diverter with P8RI coating
- Chemerin in caudal division of nucleus tractus solitarius increases sympathetic activity and blood pressure
- Alpha2 Agonist Use in Critically Ill Adults: A Focus on Sedation and Withdrawal Prevention
- Ventral tegmental area amylin receptor activation differentially modulates mesolimbic dopamine signaling in response to fat versus sugar
- Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study
- Cavbeta3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalitis
- Heparan sulfate acts as an activator of the NLRP3 inflammasome promoting inflammatory response in the development of acute pancreatitis
- Cryo-EM structures elucidate the multiligand receptor nature of megalin
- Glutamate neurotransmission from leptin receptor cells is required for typical puberty and reproductive function in female mice
- Optimizing GABAA receptor antagonism for the induction of long-term potentiation in the mouse and rat dentate gyrus in vitro
- A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies
- A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies
- Transcriptomic Analysis of Metastatic Uveal Melanoma and Differences in Male and Female Patients
- Assessing the Effects of Thiazole-Carboxamide Derivatives on the Biophysical Properties of AMPA Receptor Complexes as a Potential Neuroprotective Agent
Evidence Blueprint
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Suicidal Thoughts and Self-injurious Behavior Associated With Glucagon-Like Peptide-1 Receptor Agonists - A Review
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- AI-driven convolutional neural networks for accurate identification of yellow fever vectors
- Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype
- AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
- Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists
- Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders
- NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties
- IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders:An emerging pharmacotherapeutic target
- All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with Diminished Side Effects
- Experimental and computational biophysics to identify vasodilator drugs targeted at TRPV2 using agonists based on the probenecid scaffold
- Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo
- Postoperative use of sleep aids and delirium in older adults after major surgery: A retrospective cohort study
- The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review
- The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review
- Effects of Selective and Mixed-Action Kappa and Delta Opioid Receptor Agonists on Pain-Related Behavioral Depression in Mice
- Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety
- The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception
- Mechanisms of biased agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor
- Estradiol and Mu opioid-mediated reward: The role of estrogen receptors in opioid use
- Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice
- Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPARα agonists by in silico studies and biochemical evaluation
- Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening
- µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice
- Underlying mechanisms for psychotropic effects of delta opioid receptor agonists
- Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening
- A µ-opioid receptor modulator that works cooperatively with naloxone
- Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR delta activation
- A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
- International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
- International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
- P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier
- Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
- Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
- Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
- Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
- Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans
- Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease
- The emerging role of glucagon-like peptide-1 in binge eating
- The emerging role of glucagon-like peptide-1 in binge eating
- Glucocorticoid receptor modulator CORT125385 alleviates diet-induced hepatosteatosis in male and female mice
- Synthesis and biochemical evaluation of 17-N-beta-aminoalkyl-4,5α-epoxynormorphinans
- Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837
- Melanocortin agonism in a social context selectively activates nucleus accumbens in an oxytocin-dependent manner
- Discriminative stimulus properties of Cannabis sativa terpenes in rats
- Sub-second Dopamine Signals during Risky Decision-Making in Patients with Impulse Control Disorder
- Possible involvement of FFAR1 signaling in mouse emotional behaviors through the regulation of brain monoamine releases
- PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression
- Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors
- Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- Biguanides and glucagon like peptide 1 receptor agonists in the amelioration of post liver transplant weight gain; a scoping review of the mechanism of action, safety and efficacy
- Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity
- Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial
- Optogenetic determination of dynamic and cell-type-specific inhibitory reversal potentials
- GFP and FAP imaging of neuropeptide release in Drosophila
- Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease
- Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease
- Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease
- Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease
- Sex differences and sex-specific regulation of motivated behavior by Melanin-concentrating hormone: a short review